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2Abstract
Mapping cerebrovascular reactivity (CVR) to hypercapnia is important both clinically and
for improved understanding of the haemodynamic properties of the BOLD effect. In this
work BOLD/R2* CVR was investigated by using a device which provided small,
repeatable and stable steps in PETCO2, whilst maintaining a steady PETO2 level.
Significant CVR was observed in both grey and white matter at both 3 & 7T, whilst an
approximately linear relationship found between R2* CVR and field strength has
implications for BOLD models and calibration. Grey matter R2* CVR was 0.066±0.004
s-1 mmHg-1 at 3T and 0.141±0.008 s-1mmHg-1 at 7T. White matter R2* CVR was
0.021±0.003 s-1mmHg-1 at 3T and 0.040±0.007 s-1mmHg-1 at 7T.
3Introduction
The ability of the body to modulate cerebral blood flow (CBF) is important both
clinically and in understanding the haemodynamic response to neuronal activation. The
cerebral vasculature has considerable vascular constrictor and dilator reserves. CBF is
very sensitive to changes in arterial PCO2 (PaCO2), increasing 4-6% per 1 mmHg increase
in PaCO2 (Noth et al. 2006; Pollock et al. 2009). On the other hand previous studies
suggest mild hypercapnia does not significantly alter CMRO2 (Davis et al. 1998; Chen
and Pike 2009). Therefore in response to hypercapnia the concentration of
deoxyhemoglobin [dHb] in venous blood decreases dramatically causing a BOLD signal.
Cerebrovascular reactivity (CVR) as measured by BOLD MRI is defined as the change in
BOLD signal in response to a change in PaCO2 and provides a measure of the capacity of
vessels to react to a stimulus. This technique has been applied to map the regional
distribution of CVR in cerebrovascular disease such as stroke and carotid artery stenosis
and occlusion (van der Zande et al. 2005; Mandell et al. 2008). The BOLD CVR is also
of particular interest since it is used in calibrated BOLD: either the functional BOLD
response to a task is divided by the BOLD response to mild hypercapnia on a voxel-by-
voxel basis, or alternatively the functional BOLD response to a task is used to estimate
δCMRO2 based on the model of Davis et al.(Davis et al. 1998).
Many studies (Kastrup et al. 2001; Vesely et al. 2001; van der Zande et al. 2005;
Wise et al. 2007; Prisman et al. 2008) have measured BOLD CVR by inducing a step
change in PaCO2. Since direct measurement of PaCO2 is invasive, the exhaled ‘end-tidal’
PCO2 (PETCO2) of expired gases is sampled instead. Cohen (Cohen et al. 2004) used a
single step change in PETCO2 (5% CO2 for 3 minutes) and showed that BOLD CVR
increased with field strength (considering 1.5, 4 & 7T). Mandell (Mandell et al. 2008)
found a close correlation between BOLD and CBF changes in response to a single step
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CO2) and Stefanovic (Stefanovic et al. 2006) (5, 7.5 and 10% CO2) measured both CBF
and BOLD signal changes in response to multiple steps in PETCO2 to estimate CMRO2.
Posse (Posse et al. 2001) modulated PETCO2 from 20-70 mmHg, to probe T2* CVR over a
large range. With the exception of Hoge (Hoge et al. 1999), all the studies have used
large steps in PETCO2 (≥10mmHg), to provide good contrast-to-noise ratio (CNR) in the 
CVR measurement. However, such large steps prevent a thorough examination of the
relationship between CVR and PaCO2.
MR studies of CVR have variously studied changes in the BOLD signal or T2*.
However it is the change in R2* (determined by the change in blood volume and
oxygenation (Yablonskiy and Haacke 1994)) that is the primary haemodynamic response
to an increase in blood flow, rather than the BOLD effect, which also depends on the
baseline R2* and potentially blood inflow effects.
The aim of this study was to assess the dependence of R2* CVR on PaCO2 over the
normal physiological range and to investigate how the BOLD signal resulting from this
controlled challenge varies with field strength, between 3T and 7T. As field strength
increases, the intrinsic signal-to-noise-ratio (SNR) and the R2* and hence BOLD signal
increases and the contribution of blood to the total signal decreases (Yacoub et al. 2001;
van der Zwaag et al. 2009). Therefore a cross-field study of the effect of CVR on the
BOLD signal will provide some insight into the underlying mechanisms of the BOLD
effect. We used a RespirAct™ system (Thornhill Research Inc., Toronto, Canada) to
apply precise, small, well tolerated, iso-oxic step changes in PETCO2 in a pseudo random
order. The BOLD and PETCO2 data was analysed on a point by point basis to include data
generated during the PETCO2 transitions and thus sample a wider range of PETCO2 levels.
5Methods
Five healthy males with a mean age of 25 years (range 23-29 years) took part in
the study. Approval for the study was obtained from the University of Nottingham
Medical School Ethics Committee and all subjects gave written informed consent.
Control of end-tidal gas
A feed-forward, low gas flow system (RespirAct™, Thornhill Research Inc.,
Toronto, Canada) and a sequential gas delivery (SGD) breathing circuit (Figure 1)
(Banzett et al. 2000; Slessarev et al. 2007) were used to target PETCO2 and PETO2
independently (Slessarev et al. 2007). Source gases used by the system were O2, air, and
two gas blends of N2, CO2 and O2, so that all source gases were of safe O2 concentrations.
The Respiract™ follows the approach of Slessarev et al. (Slessarev et al. 2007) to
calculate the required flows of these source gases into the SGD breathing circuit to attain
the targeted PETCO2 and PETO2.
The system comprises of an inspiratory and exhaled gas reservoir. During gas
delivery, the subject was instructed to empty the inspiratory gas reservoir with every
breath. Additional inspired gas, if required, was then drawn from the exhaled gas
reservoir through a second valve that opens once the inspiratory reservoir is collapsed (as
previously exhaled gas has already equilibrated with the blood, breathing in this gas has
no effect on gas exchange). Gas exchange is therefore determined solely by inhaling the
gas supplied, independent of ventilation. The gas exchange for CO2 and O2 are controlled
independently using the same approach (Slessarev et al. 2007). An important aspect of
this system is that it reduces regional gas gradients in the lung, thus the PETCO2 provides
as good a measure of PaCO2 as direct arterial blood analysis (Ito et al. 2008).
6Protocol
The face mask of the breathing circuit was placed comfortably on the face of the
subject and skin tape (Tegaderm, 3M Health Care, St.Paul, MN) was used to assure an
air-tight seal to the face. The subject was then positioned in the magnet. The gas supply
and sample tubing were passed through a wave guide to the control room where they were
connected to the Respiract™. Prior to performing the CO2 challenge, subjects simply
breathed medical air through the system. Target end-tidal values were entered into the
Respiract™, which prospectively calculated the delivered gas concentrations to achieve
the targets based on estimated metabolic values. During the respiratory challenge,
subjects were visually cued to breathe at approximately 15 breaths/min (between 6 and 24
breaths/min, the actual breathing frequency does not affect the results (Ito et al. 2008))
and sufficiently deep to always empty the inspiratory gas reservoir. Prior to placing the
subject in the magnet, required metabolic values were estimated iteratively by targeting a
baseline (40 mmHg PETCO2, 100 mmHg PETO2) and refining the metabolic estimates so
that the baseline is achieved. The hypercapnic challenge consisted of an initial 3 minute of
baseline PETCO2 (40 mmHg) period followed by 2 minute period of a target PETCO2 level,
followed by 1 minute of baseline with this cycle repeated 5 times to include PETCO2
levels of 49, 43, 37, 40 or 46 mmHg, presented in the pseudo-randomised order. PETO2
was targeted at 100 mmHg throughout the sequence. Following the CO2 challenge,
PETCO2 was set to baseline for 1 min before returning to spontaneous ventilation on air.
Image Acquisition
MR scanning was performed on a Philips Achieva 3.0T system, with a whole body
volume transmit and 8-ch SENSE head receive coil, and a Philips Achieva 7.0T system,
with head volume transmit and 16-ch SENSE head receive coil. Axial images were
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ms with 30 ms readout per echo at 3T, TE = 20/57 ms with 37 ms readout per echo at 7T);
TE values were optimised for R2* measurement rather than BOLD contrast, 192x192 mm
FOV, 2x2x3 mm3 voxels with 9/10 slices (3T/7T), and no slice gap, in a TR of 1.5 s.
Figure 3 shows the typical slice coverage at both 7 and 3 T. For tissue segmentation
inversion-recovery (IR)-EPI images were acquired with the same geometry, with grey
matter (GM), white matter (WM) and CSF nulled (TI = 600/900/1900 ms at 3T and TI =
600/1100/2200 ms at 7T). For vein segmentation a high-resolution (0.8mm isotropic) T2*-
weighted fast field echo (FFE) FLASH (TR/TE = 50/20 ms, EPI factor = 3, BW = 167
Hz) image which minimizes geometric distortions was also acquired at 7T.
Data Processing
All data pre-processing was performed using FSL (FMRIB, Oxford, UK).
EPI data acquired during the hypercapnic challenge was motion corrected (separately at 3
& 7T) by realigning the shorter TE images to the first dynamic using MCFLIRT
(Jenkinson et al. 2002), then applying the registrations to both TE images. R2* was
calculated on a voxel-by-voxel basis from the difference in the log of the signal at each
echo time, divided by the difference in echo time. The IR-EPI images were then
segmented (BET and FAST, FSL) to generate a GM mask and GM, WM and CSF partial-
volume estimates. The WM mask only included voxels that were estimated to be at least
99% WM, to avoid significant partial-voluming from GM reactivity. It was not possible
to time lock the MR acquisition and PETCO2 time course, and so the breath-by-breath
PETCO2 trace was linearly interpolated to match the sampling frequency of the MR data,
and then manually shifted to temporally align the PETCO2 timecourse with the R2*
timecourse averaged over all GM voxels (estimated error is one interpolated time point).
This allowed the actual level of PETCO2 and R2* to be compared on a point-by-point basis
8across a range of PETCO2 levels (rather than simply comparing the signal change at
prescribed PETCO2 levels). Linear regressions were performed to calculate average GM
and WM R2* CVR to PETCO2, defining R2* CVR as the absolute change in R2* (measured
by the gradient of the linear regression) for a 1 mmHg change in PETCO2. The fit
uncertainties were used to assess the error in R2* CVR.
The SNR in the R2* data was not adequate to allow R2* CVR maps to be
produced. Instead BOLD CVR maps were generated combining the double echo data; the
SNR in the BOLD data was increased by weighted summation of the EPI images acquired
at each echo time (Posse et al. 1999), with the weighting based on a T2* map calculated
from the average baseline signal at both echo times. This was done for each time point
and on a voxel-by-voxel basis and the resulting time course was then normalized to the
baseline and baseline corrected ((weighted sum signal/average baseline weighted sum
signal) – 1), where the baseline was defined as the 40 mmHg PETCO2 step. For each
voxel, the normalized, baseline corrected, summed BOLD signal was plotted against the
PETCO2 signal on a time point by time point basis, after temporal alignment. The gradient
of the linear fit to this plot was used to map BOLD CVR on a voxel-by-voxel basis. The
fit uncertainties were used to assess the errors in BOLD CVR.
In order to consider the R2* CVR of tissue alone, excluding large vessels, the
FLASH T2*-weighted image acquired at 7T was used to identify veins, since at 7T veins
have a shorter T2* and so lower signal intensity than the surrounding tissue. Initially
regions outside of the brain were removed from the images using the brain extraction tool
(BET) in FSL (Smith 2002). The image was then inverted, so that voxels dominated by
veins had a high intensity, a third-order polynomial filter was then applied to remove
large-scale inhomogeneities and nearest-neighbour smoothing performed. The smoothed
image was then subtracted from the unsmoothed image to locate voxels with a significant
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voxels dominated by veins and cluster analysis performed to remove any isolated voxels.
The FLASH image was resized to 2x2x3 mm3 and co-registered to both the 7T and the 3T
EPI datasets and these transformations were then applied to the resized binary mask. This
mask was applied to the R2* time-series to remove these voxels before averaging, thus
allowing a comparison of GM and WM R2* CVR with and without the inclusion of large
vessels.
Results
Similar changes in PETCO2 level were achieved across all subjects. Figure 2
shows a representative subject. Across all subjects the step sizes were consistently a third
less than targeted. Despite this, clearly resolvable PETCO2 transitions were achieved (Fig.
2b) whose level was well maintained over the 2 minute period. The PETO2 levels reached
a steady state within the initial 3 minute baseline period (Fig. 2c) and then had a
maximum range of 5 mmHg (across all subjects and all PETCO2 challenges).
The R2* time-courses closely followed the PETCO2 time-course at both field
strengths (Fig. 2a). The BOLD CVR maps show good GM contrast at both field strengths
(Figure 3) and clear distinction between grey matter and white matter. Increased reactivity
is observed in the 7T compared to 3T CVR maps. Table 1 shows individual GM R2*
reactivities both including and excluding voxels dominated by veins. Figure 4(a,b) plots
the GM averaged R2* reactivity at 7 and 3T including data for each of the five subjects.
Average GM R2* reactivities agreed well between subjects (Figure 4). Including voxels
dominated by veins, GM R2* CVR was 2.0±0.4 times higher at 7T than at 3T (averaged
over all subjects): GM R2* CVR was 0.074±0.007 s-1mmHg-1 at 3T and 0.145±0.020 s-
1mmHg-1 at 7T. Excluding voxels dominated by veins GM R2* reactivity was 2.1±0.5
times higher at 7T than at 3T (averaged over all subjects): GM R2* CVR was 0.066±0.004
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s-1 mmHg-1 at 3T and 0.141±0.008 s-1mmHg-1 at 7T. There was a significant increase in
the GM R2* CVR 7T/3T ratio between the case when vessels were included and when
they were excluded (P =0.06, Wilcoxon paired). Contrast-to-noise ratio (CNR) was
calculated for GM R2* CVR as 0.88 mmHg-1 at 7T and 0.98 mmHg-1 at 3T. This was
calculated by dividing the GM R2* CVR by the variance (GM R2* standard deviation) of
the 40 mmHg PETCO2 step, averaged over all subjects.
The paradigm provided sufficient sensitivity to detect an average WM R2* CVR
(Table 2) of 0.021±0.003 s-1mmHg-1 at 3T and 0.040±0.007 s-1mmHg-1 at 7T with veins
removed. Figure 4(c,d) plots the WM averaged R2* reactivity at 7 and 3T for each of the
five subjects.
Discussion
This study has combined a versatile and accurate method for controlling and
measuring PETCO2 and PETO2 with a quantitative R2* measurement to provide a new time
point-by-time point approach to monitoring CVR using MRI. Small, readily tolerable
steps in PETCO2 over a naturally occurring range of PETCO2 (37 – 49 mmHg) were used.
The rapid sampling of the PETCO2 and MR data allowed point-by-point temporal analysis
which improved sensitivity in CVR, allowing measurement of GM reactivity and
detection of significant WM reactivity, at both 3 and 7T.
The technique to control blood gases used in this study allowed independent
control of PETCO2 and PETO2, to provide transitions to and between stable PETCO2 levels,
whilst maintaining PETO2 at a constant level (Slessarev et al. 2007). PETCO2 transitions
were achieved within one or two breaths. It is essential that a constant level of PETO2 is
maintained, as the BOLD signal is modulated by the O2 content (hyperoxia) of the blood
which could otherwise confound the relationship between CBF changes and BOLD signal
(Prisman et al. 2008). Increasing PaO2 above resting levels, in which arterial haemoglobin
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is near fully oxygenated, dissolves more O2 in blood plasma. This pool of O2 then spares
the O2 that would be extracted from oxygenated-haemoglobin, and thus reduces the
venous [dHb]. To date, few approaches that change PETCO2 to probe the relationship
between hypercapnia and BOLD signal have controlled PETO2. Simple breath holding,
which has the advantage of requiring no additional equipment (Kastrup et al. 2001;
Scouten and Schwarzbauer 2008), does not generate repeatable stimulus levels (due to
inter-subject and inter-session variability in resting metabolism) (Bulte et al. 2009), does
not allow lung gas to be monitored during the breath-hold (as no gas is exhaled), and
produces a coupled reduction in PaO2 (Sasse et al. 1996). Alternatively, PETCO2 is often
modulated by providing two different inspired gas mixtures, typically containing oxygen,
nitrogen and either 0% CO2 (baseline) or 5% CO2 (hypercapnic challenge) (Davis et al.
1998; Cohen et al. 2004; Wise et al. 2007). However the level of PETCO2 that is achieved
using such a method depends on the particular ventilatory response of the volunteer.
Since inhaling CO2 causes hyperventilation, PETO2 will rise even if the inspired PO2 is
constant. PETCO2 and PETO2 can be controlled independently by a method termed
dynamic end-tidal forcing (Wise et al. 2007). This method uses a computer controlled
feedback mechanism to correct the supplied gas concentrations based on breath-by-breath
sampling of PETCO2 and PETO2. However, feedback mechanisms are hampered by the
delay and dampening of the exhaled gas changes over the time they take to reach the gas
sensors, which have to be positioned far from the subject in high-field experiments. Thus
with dynamic end-tidal forcing, PETCO2 may not provide a good estimate of PaCO2 (St
Croix et al. 1995).
Previously, T2* (not R2*) CVR has been measured (Posse et al. 2001), with a non-
linear relationship observed over large (10 mmHg) PETCO2 steps. PETO2 was not
controlled and the high gas flow rates used to achieve high (70 mmHg) and low (20
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mmHg) PETCO2 target levels would have induced hyperventilation, leading to increased
PETO2 (not monitored), arterial oxygenation and a further increase in T2*, which may have
accounted for some of the non-linearity. However, a rough conversion of their results
from T2* to R2*(=1/T2*) shows an approximately linear relationship between R2* and
PETCO2 from 40-60 mmHg.
This study used high spatial resolution compared to previous CVR studies, which
will have reduced partial volume effects between GM and WM, and allowed us to exclude
venous vessels. In this study we found an increase in R2* CVR with field strength, which
is consistent with previous cross-field BOLD CVR studies (Cohen et al. 2004).
Removing voxels with large venous components reduced the R2* CVR at both field
strengths, consistent with the intravascular/perivascular signal dominating the BOLD
signal change. Furthermore this reduction in reactivity was larger at 3T than 7T. This is
expected since the R2* of blood is much greater at 7T, so the direct signal contribution
from blood is reduced.
The results also suggest that the power law relating the change in R2* to frequency
shift (due to change in relative intravascular susceptibility or field strength) is close to
linear (7/3=2.3) between 3 and 7 T, and by excluding voxels dominated by veins the
7T:3T R2* reactivity ratio was increased. Yablonskiy (Yablonskiy and Haacke 1994)
predicted a linear relationship for extravascular dephasing if vessels were assumed to be
randomly orientated. A linear relationship between R2* and frequency offset is expected
in the static dephasing regime, whereas supralinear relationships are associated with
intermediate and fast dephasing regimes. The effect of diffusion on transverse relaxation
around a vein will depend on vessel size and frequency offset due to the vein as well as
echo time. For the echo times used here, as the frequency offset increases, the vessel size
at which the static dephasing limit dominates decreases (Kennan et al. 1994). Monte Carlo
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simulations predict supralinear behaviour at 1.5T (Ogawa et al. 1993; Davis et al. 1998),
with 3T being the boundary between linear and supralinear behaviour (Boxerman et al.
1995). It should be noted that the BOLD calibration method (Davis et al. 1998) was first
developed at 1.5T and so the power law relationship proposed in that work between
intravascular oxygenation and R2* (1.5) may not be appropriate at higher fields. For WM
the power law does seem to be <1. WM has a different vascular structure with much
smaller blood volume than GM, and also restricted extravascular water diffusion (due to
myelination of the axons), and this might alter the relationship between intravascular
susceptibility, the microscopic field distribution in the tissue and the resulting R2*.
However this requires further investigation since WM reactivity data must be interpreted
with caution due to the reduced SNR of this data.
The relationship between R2* and PETCO2 depends on the relationship between
CBF and PETCO2, CBV and CBF (power law described by Grubb’s constant (Grubb et al.
1974)), CBF and venous blood oxygenation, and the resulting relationship between CBV
and venous blood oxygenation and R2*. As discussed above, Monte Carlo simulations
and the cross field data presented here and elsewhere (van der Zwaag et al. 2009), suggest
the relationship between venous blood oxygenation and R2* is linear at 3 and 7T.
Furthermore it has been shown (Reivich 1964) in anesthetised rhesus monkeys that the
relationship between PaCO2 and CBF is sigmoidal over the PaCO2 range of 5-418 mmHg,
centred on the natural resting value of PaCO2 of 40 mmHg, but that over the normal range
of PaCO2 values the relationship between PaCO2 and CBF is linear (in that study changes
in PaO2 were also found to have no effect on CBF). Therefore the simplest interpretation
of the linear relationship observed here would be that the relationship between CBF and
CBV is linear (ie Grubbs constant =1), although this assumes that the relationship
between CBF and oxygenation is approximately linear. However this argument is made
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for a global challenge and may not be appropriate when considering the effects of local
challenges (e.g. response to neuronal activation) where the haemodynamic effects may be
somewhat different.
In this study, the gas sampling data could not be electronically time locked to the
scanner acquisition due to hardware limitations, and so the respiratory sequence was
manually synchronized with the imaging sequence (~ ± 1.5s). There was also a delay
between gas delivery and sampling of about 5 seconds caused by the transit time between
the mask and the gas sensors residing outside the 3mT magnetic field line. The data
signals therefore had to be aligned manually during processing, and so it was not possible
to estimate the delay between the PETCO2 change and associated CVR. This could
potentially add noise to the R2* CVR curves but this effect will not be significant since
the PETCO2 data were resampled from ~6s sampling interval to 1.5s sampling interval. It
is interesting to note that there was a close correlation between PETCO2 stimulus and the
associated BOLD response on both the up and down transitions, with no sign of a post
stimulus undershoot, suggesting that the post stimulus undershoot often observed in the
BOLD signal evoked by neuronal activation is not vascular in origin (Mandeville et al.
1999), although further experiments are required to confirm this conclusion.
The echo times used in this study were chosen to optimize the estimate of R2*,
although hardware limitations meant that the optimal (short) echo times required at 7T
could not be reached. Therefore although better contrast was achieved at 7T, similar
contrast-to-noise was observed at both field strengths in GM due to the non-optimal TE
and increased physiological noise at 7T, shown by increased R2* variance at 7T over 3T
(p<0.003). This agrees with the findings of Triantafyllou et al. (Triantafyllou et al. 2005).
Respiratory noise was particularly pronounced because of pacing of the respiratory cycle
and because the subjects increased their depth of breathing during the respiratory
15
challenge. This can be seen in Figure 2a, where there is a ~6s oscillation throughout the
BOLD timecourses. Physiological noise correction methods, such as RETROICOR
(Glover et al. 2000) could be used in future work to reduce the respiratory noise, although
this would require an additional measurement of chest movement. However the
RETROICOR algorithm employs a high-pass filter for linear de-trending, which will also
remove some of the reactivity for the paradigm used here, especially as the stimulus is
time-locked to the respiratory cycle. An alternative to retrospective correction is to
actively perform dynamic shimming (van Gelderen et al. 2007) to correct for the gradient
changes through the respiratory cycle. A sinusoidal CO2 stimulus (Blockley et al. 2009)
might be less affected by respiratory noise if the stimulus frequency were made
significantly different from the respiratory noise frequency.
During a long fMRI experiment, variations in PaCO2 that are likely to occur as a
subject relaxes, will lead to a baseline drift in the BOLD signal. This study has shown
that R2* reactivity to PaCO2 is linear over the typical range of these changes, and so to the
first approximation (for a small change in R2*) the effect can be removed simply by linear
de-trending of the BOLD signal time course. However if the functional stimulus also
caused changes in PaCO2, through changes during the respiratory cycle (e.g. where the
stress of performing a task increases respiration), then the resulting BOLD signal change
would be on the same timescale as the functional BOLD response, producing a systematic
error in the fMRI response.
An alternative MR-based method for monitoring CVR with MRI could be to use
arterial spin labelling (ASL) to measure CBF. Mandell (Mandell et al. 2008) found a
close correlation between BOLD and ASL measurements of CVR. Although ASL based
methods are a more direct measurement of CVR, they have an intrinsically lower signal-
to-noise ratio and they generally provide a lower temporal resolution than BOLD.
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However combined measurements of CBF and R2* changes in response to CVR to
PETCO2 could provide useful information with which to test models of aspects of cerebral
haemodynamic changes in response to neuronal activation (Buxton et al. 1998; Blockley
et al. 2009).
Future work will use this paradigm in clinical studies of cerebrovascular disease
(van der Zande et al. 2005; Mandell et al. 2008) and will use the respiratory challenge to
investigate the steady state relationship between CBF, blood volume and blood
oxygenation.
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Tables
GM average including R2* reactivity (s-1mmHg-1)
venous voxels 7T 3T 7T/3T
Subject 1 -0.173±0.005 -0.067±0.004 2.6
Subject 2 -0.146±0.009 -0.086±0.005 1.7
Subject 3 -0.163±0.008 -0.072±0.004 2.3
Subject 4 -0.133±0.010 -0.075±0.002 1.8
Subject 5 -0.109±0.006 -0.073±0.005 1.5
Mean (across subjects)
± Standard deviation -0.145±0.025 -0.074±0.007 2.0±0.4
GM average with R2* reactivity (s-1mmHg-1)
venous voxels excluded 7T 3T 7T/3T
Subject 1 -0.168±0.005 -0.058±0.004 2.9
Subject 2 -0.134±0.009 -0.081±0.005 1.7
Subject 3 -0.163±0.008 -0.070±0.004 2.4
Subject 4 -0.128±0.009 -0.065±0.002 2.0
Subject 5 -0.109±0.006 -0.060±0.005 1.8
Mean (across subjects)
± Standard deviation -0.141±0.025 -0.066±0.009 2.1±0.5
Table 1: GM R2* reactivity for all subjects, calculated using a linear regression.
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WM average with R2* reactivity (s-1mmHg-1)
venous voxels excluded 7T 3T 7T/3T
Subject 1 -0.035±0.006 -0.001±0.002 *31.7
Subject 2 -0.031±0.011 -0.020±0.002 1.6
Subject 3 -0.061±0.009 -0.028±0.004 2.2
Subject 4 -0.050±0.005 -0.036±0.003 1.4
Subject 5 -0.022±0.004 -0.020±0.002 1.1
Mean (across subjects)
± Standard deviation -0.040±0.015 -0.021±0.013 *1.6±0.5
Table 2: WM R2* reactivity for all subjects, calculated using a linear regression.*The
7T/3T ratio for Subject 1 is treated as an outlier and has been ignored in the cross-subject
mean calculation.
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Figures
Figure 1: Sequential Gas Delivery (SGD) circuit, based on Slessarev (2007). Upon
inspiration, gas flows from the inspiratory gas reservoir to the mask. If the inspiratory gas
reservoir is collapsed, the valves switch so that gas from the exhaled gas reservoir flows
into the mask. Upon expiration, the valves prevent exhaled gas from entering the
inspiratory gas reservoir. The exhaled gas reservoir features two slits in the bottom
corners which act as vents.
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Figure 2: Corresponding time-courses for (a) GM average -R2* (veins excluded),
measured (b) PETCO2 and (c) PETO2. -R2* is plotted to show the tight linear correlation
between PETCO2 and -R2*. The dotted vertical line indicates the end of the initial baseline
period. The dashed trace shows targeted PETCO2 levels. (Subject #5 at 7T)
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Figure 3: Localiser showing typical slice coverage and corresponding CVR maps of
subject #5 at 7T and 3T. The scale ranges from 0 to 2.5%/mmHg signal change and the
middle 5 slices are shown.
Figure 4: GM averaged R2* reactivity at (a) 7T and (b) 3T and WM averaged R2*
reactivity at (c) 7T and (d) 3T for all subjects (veins excluded). Averaged R2* reactivity
is shown by the scatter plots and linear fits are shown as lines. Each subject is plotted in a
different colour.
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